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ABSTRACT 
 
Martínez-Patiño MJ, Mateos-Padorno C, Martínez-Vidal A, Sánchez AM, García JL, Díaz MP, Touriño CF. 
An approach to the biological, historical and psychological repercussions of gender verification in top level 
competitions. J. Hum. Sport Exerc. Vol. 5, No. 3, pp. 307-321, 2010. Different kinds of disorders of sex 
development (DSD) have been observed in athletes from different countries along the history of sport. The 
detection of an abnormal chromosomal pattern or gonadal dysgenesis has been always associated to the 
gender verification tests which international sports institutions have performed from 1960s and abandoned 
as systematic practice in 2000. Such methods have been heavily criticized by specialists of different fields 
such as genetics, endocrinologists and psychologists. The use of a femininity control at the present days to 
detect possible males who fraudulently pretend to compete in female only events is inconsistent. The 
possible decision of the International Olympic Committee to establish special centers to manage future 
DSD cases is also discussed. A major concern on the confidentiality between doctors and patients and the 
establishment of care protocols for the psychological support of athletes in such delicate situations is 
needed. This ties altogether with the psychological and social repercussions of the gender verification on 
the lives of athletes with DSD.  When cases of sex ambiguities are detected, issues such as the respect of 
privacy, the need of specific protocols to follow with flexible and diversified tests considering the 
particularity of each case as well as the psychological support of the athletes and their family have to be 
taken into account. Although health tests are needed for both men and women, DSD athletes should not be 
discriminated for their genetic pattern and they should be allowed to compete as it occurs with other 
athletes with genetic affections which do not involve the sex and that give them a phenotypical advantage 
over other athletes. Key words: GENDER TEST, DISORDERS SEX DEVELOPMENT (DSD), GENDER 
VERIFICATION, SPORT, FEMALE 
                                                 
1 Corresponding author. Faculty of Science Education and Sport, University of Vigo. Campus A Xunqueira s/n. 36005 
Pontevedra, Spain. 
      E-mail: mjpatino@uvigo.es 
 Submitted for publication July 2010. 
 Accepted for publication September 2010. 
      JOURNAL OF HUMAN SPORT & EXERCISE ISSN 1988-5202  
 © Faculty of Education. University of Alicante  
 doi:10.4100/jhse.2010.53.01 
Review Article 
Martínez-Patiño et al. / Gender verification in top level competitions                        JOURNAL OF HUMAN SPORT & EXERCISE                                  
308 | 2010 | ISSUE 3 | VOLUME 5                                                                                   © 2010 University of Alicante 
 
INTRODUCTION 
 
Along the history of sport, a large number of cases of gender disorders has been reported. Before any 
athlete is allowed to compete in women’s events at the Olympics, and many other international meetings, 
she first has to prove she is a woman. Passing this screen test – known as “gender verification” or “sex 
texting”—has nothing to do with the way a woman looks, her birth records, or her sense of self. Testing 
began in the mid 1960s in response to rumors about men masquerading as women and of women “who 
weren’t really women” in competition. The purpose, officially stated by the International Olympic 
Commmittee (IOC) is to “guarantee physical equality” and prevent ”unfair, male-like competition”. There is 
no telling how many hundreds, probably thousands, of girls have either “self-disqualified” prior to 
competition; or been disqualified at lower levels of sport (including via “pre-testing” at regional training 
centers), where screening based on IOC example has been done on a widespread basis with no 
guarantees for quality control. Test data is supposed to be kept confidential, according to standard medical 
practice. 
 
The whole procedure will start with a gender testing method which varied from undressing in front of a 
panel of gynaecologists, to the external genitalia examination, chromosome analysis and the application of 
the x-chromatin test, use of modern PCR based genetic tests. There was a strong pressure to provide a 
rapid gender determination with limited information, leading to discriminating episodes. Athletes who did not 
consent to subjugate to a gender test (such as the track and field athletes Tamara and Irina Press) were 
excluded from competitions being automatically considered as men (Anonymous, 1967; Carlson, 2005). 
Others, such as the sprinter Ewa Klobukowska and the hurdler Maria Patiño, who did not suspect 
irregularities in their chromosome arrangement were also penalized by the gender verification system and 
had their sport careers and personal lives irremediably destroyed (Carlson, 2005; Martínez-Patiño, 2005). 
Maria Patiño, one of the authors of this review, struggle to appeal her disqualification from sport and with 
the help of sports and medicine specialists was the first person to be readmitted as a woman for sport. Her 
efforts represented the first step towards the abolition of the gender verification testing at international 
competitions, commencing from the Sidney Olympic Games in 2000 (Genel, 2002). The recent events 
concerning the gender verification of the 800 meters female world champion Caster Semenya and the 
determination of her disorder of sex development highlighted the problem and deserve a consideration.  
Unfortunately, the IOC had inadvertently sold the sports community a false “bill of goods”: its assessment of 
both purpose and potential for sex chromosome screening in sports was based on a naïve science, and 
proves to have been severely flawed. Concerned medical specialists have protested since the beginning 
that such screening is inaccurate, discriminatory and the cause of sometimes severe trauma in the lives of 
women athletes. 
 
The aim of the present review attempts to make a point about the disorders of sex development (DSD) and 
the gender verification system in top-level sport, taking into account different aspects, such as the clinical 
profile of DSD and the psychological and social implications of these abnormalities for women in sport. The 
issue goes beyond sport and medicine to the very essence of our scientific paradigm, and to our 
sociocultural constructs of masculinity and femininity. The implications of the debate cut right to the heart of 
our identity, and demand a re-examination of our notions of femininity, equality and fair play. 
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CLINICAL PROFILE OF DSD IN SPORT  
 
There are different factors which combined make up the sex of an individual and gonad differentiation and 
which involve a complex interaction of developmental pathways (Berkovitz & Seeherunvong, 1998). 
Although in many cases no definitive causes for the disorder can be found, it seems to be due to 
chromosomal and monogenic disorders which inhibit or change primarily genetic or endocrine pathways of 
normal sex development (Thyen et al., 2007).  
 
The genetic material for male differentiation is located in the Sry (sex determination region of the Y) gene at 
the distal region of the short harm of the Y chromosome (Fechner, 1996), which at the sixth week of 
development leads to the gonad induction according to the XY chromosomal material (Grumbach & Conte, 
1998). Sry gene is expressed in a small group of somatic cells of the developing gonads, and it is 
responsible for the expression of a male-specific cell membrane component (the H-Y antigen; Hipkin, 1993) 
and induces them to become Sertoli cells, which are responsible for sexual development of male pathway. 
The timing of when various genes and nuclear transcription modifiers are expressed can be critical in 
gonadal development and in ductal development and regression. Sex differentiation begins at about six 
weeks of embryonic life. After that, during the seventh week, primary sex cord and seminiferous evetubules 
develop in the testis (Francavilla et al., 1990; Rabinovici & Jaffe, 1990), while the primary follicles develop 
in the ovary during the tenth week (Hughes, 2002). During the sixth week, the mesonephric duct (wolffian 
duct) generates the male genital vas deferens, seminal vesicles and epidydimis, and the müllerian duct 
generates the female genital fallopian tubes, uterus and proximal vagina (Rey et al., 2002).  
 
Sertoli cells present in the male gonads produce a müllerian inhibiting substance (MIS) which determines 
the regression of the müllerian duct. The contemporary secretion of the hormone testosterone by Leyding 
cells and the following transformation into dihydrotestosterone (DHT) by the enzyme 5-α-steroid- reductase 
stimulates the development of the wolffian ducts, so that external genitalia are phenotypically male (Hipkin, 
1993; Pajkrt & Chitty, 2004). DHT is the most potent androgen in the majority of tissues, but its action 
requires the presence of an intracellular androgen receptor (Hipkin, 1993). When the müllerian inhibiting 
substances are absent the müllerian duct develops and the external genitalia are phenotypically female 
(Hipkin, 1993; Bomalaski, 2005). 
  
Disorders of sex development (DSD) is a generic term encompassing any problem noted where genitalia 
are atypical in relation to chromosome and gonads (Lee et al., 2006) and nowadays it is used to substitute 
the anachronistic nomenclature “intersex”, “hermaphrodite” and “pseudohermaphrodite”. Although the use 
of this new terminology has been questioned by some genetists and endocrinologists, we have decided to 
use it in this review because we consider that it is a more sensitive term to define this kind of conditions. 
Different kinds of DSD have been classified: gonadal dysgenesis, undervirilization of 46,XY individuals and 
prenatal or postnatal virilisation of 46,XX individuals (also known as XY DSD and XX DSD), true 
hermaphrodites, XXY karyotype of Klinefelter's syndrome (Hipkin, 1993; Richter-Appelt, 2007; Hughes, 
2008; Warne & Raza, 2008). 
 
Gonadal dysgenesis refers to a defect in gonad formation that is characterized by a progressive loss of 
primordial germ cells in the embryo with consequent formation of hypoplastic and disfunctioning gonads 
mainly composed of fibrous tissue, named streak gonads. It may be due to Turner syndrome and its 
variants (i.e. mosaicism), to XX gonadal dysgenesis (pure gonadal dysgenesis 46XX), Swyer syndrome 
(pure gonadal dysgenesis 46XY), Perrault syndrome (XX gonad dysgenesis with sensorineural hearing 
loss), mixed gonadal dysgenesis and endocrine disruptors.  
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Turner Syndrome is a chromosome abnormality in which monosomy X is present, consisting in the absence 
of all or part of one sex (Ford et al., 1959; Fraccaro et al. 1959; Sybert & McCauley, 2004), with consequent 
lack of chromosomal information which causes bilateral streak gonads, short stature, webbed neck, facial 
dystrophism and sexual infantilism. When the sex chromosome is missing in some cells and not in others of 
the same individual the case is referred as Turner mosaicism (Lisker et al., 1978; Zuffardi et al., 1987) or 
when there are sex chromosomal different patterns in cells of the same individual we can also talk of 
mosaicism and in this case the subject has normal stature. A famous case of mosaicism with abnormal 
genitalia in female high level sport was given by the sprinter Ewa Klobukowska in 1967. The Polish sprinter 
was submitted to a nude parade in front of a board of gynaecologists, external genitalia examination and a 
chromosome analysis. Although she passed the phenotype tests, the chromosome analysis revealed a 
XX/XXY mosaicism, so that she was considered as a man, banned from competitions, and all her medals 
and records were retired (Langlais, 1988; Carlson, 2005). Another case of mosaicism in the chromosomal 
pattern was the 1932 track legend Stella Walsh, whose gonadal dysgenesis was revealed by an autopsy 
after her death due to a shot in a cross fire of a store robbery in 1980 (Dickinson, 2002; Carlson, 2005) 
when she had already retired from competitions for a long time. 
 
Pure gonadal dysgenesis 46XX is strictly correlated to Turner’s syndrome and individuals with this kind of 
disorders are characterized by normal female external genitalia, bilateral streak gonads, amenorrhea and 
sexual infantilism. Since the streak gonads are not able to produce estrogens or androgens, the secondary 
sex characteristics do not develop and there is not breast development, widening of the pelvis and 
menstrual period (amenorrhea). Perrault associated the XX gonad dysgenesis with sensorineural hearing 
loss (Perrault et al., 1951). Subjects with pure gonadal dysplasia and a 46XY karyotype (Swyer syndrome) 
will display variable degrees of undermasculinization dependent upon the amount of testicular dysplasia, 
being possible that in some cases the müllerian ductal structures are present due to a deficient secretion of 
müllerian inhibiting substances. Both XX and XY gonad dysgenesis are due to mutation or deletion of part 
of the sequence of the Sry gene (Dickinson et al., 2002). Surgery is possible to redirect external genital to 
female or male “normal” structures (Bomalaski, 2005).  
 
Cases of surgery to adjust the sex of some athletes to their chromosomal arrangement have been 
observed in the sport history, such as the case of the Czechoslovak runner and jumper Zdenka Koubkova 
and of the English shotputter and javelin thrower Mary Edith Louise Weston. Both individuals had sex 
change surgery and turned into men, legally changing their names to Zdenek Koubek and Mark Weston, 
respectively (“Change of sex”, 24 Agust, 1936, Time). The 1946 European Cup medallist, Lea Caurla 
changed her sex after the compulsory retirement from competitions. Erika Schinegger, an Austrian ski 
champion, retired in 1967 after the detection of irregularities during the medical examination in the World 
Cup competition. After a surgery she changed of sex, competed as a man in skiing and cycling and was 
able to procreate. Another French athlete, Clare Bressolles underwent sex change surgery, married and 
fathered children (Ferguson-Smith & Ferris, 1991; Carlson, 2005). On the contrary, the Polish athlete Ewa 
Klobukowska underwent surgery to extract internal testis and followed a hormone therapy to keep on going 
with her difficult life as a woman (Facius, 2004). 
 
Mixed gonadal dysgenesis is a partial gonadal dysgenesis variant of the Y chromosome mosaicism (Kim et 
al., 2002) and the subjects have 45XO/46XY karotype being characterized by unilateral testis, a 
contralateral streak gonad, persistent müllerian ductal structures ipsilateral with the streak gonad, and 
varying levels of external genitalia undervirilization (Diamond, 2002). Two-thirds of patients are reared as 
females while subjects with highly masculinisation are reared as male with testis preservation; careful 
periodic screening of the testis must be undertaken due to the risk of malignancy (Bomalaski, 2005). True 
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hermaphroditism is very similar to mixed gonadal dysgenesis, although very rare, and consists in both 
ovarian and testicular tissues present in the same individual. The karyotype could be 47XXY, 46XX/46XY, 
or 46XX/47XXY. 
 
Endocrine disruptors are exogenous substances that act like hormones in the endocrine system and disrupt 
the physiologic function of endogenous hormones. They are sometimes also referred to as hormonally 
active agents (Krimsky, 2001) or endocrine disrupting chemicals/compounds (EDC). Low dose exposure to 
chemicals that interact with hormone receptors could interfere with the sex development and other 
hormonally mediated processes in embryo. 
 
At endocrine level, hormonal factors may play an important role in the genital phenotype. Female genital 
development is passive but an androgen stimulation of external (from the mother) or endogenous from an 
adrenal source (congenital adrenal hyperplasia) origin may cause virilisation of female genitalia (Sultan et 
al., 2002). A female pseudohermaphrodite or XX DSD is a genetic female with ovaries but virilized external 
genitalia (de la Chapele, 1981). When müllerian inhibiting substances are not produced by Sertoli cells, 
müllerian duct remains although the production of testosterone is normal. When a failure of the production 
of testosterone or of its metabolic derivates or of the androgen receptor exists (due to 21-steroid-
hydroxylase and 5-α-steroid-reductase deficiency), it is possible to observe an undervirilization and the 
generation of a male pseudohermaphrodite who has a 46XY karyotype (XY DSD) but deficient 
masculinisation of the external genitalia (Bomalaski, 2005). The case of Maria Patiño, who presented a Y 
chromosome and whose labia hid testes within, is another example of the development of an individual with 
female phenotype and female rear at birth that was treated as a male who unfairly wanted to compete as a 
woman. She was born with a condition called androgen insensitivity and although the presence of the Y 
chromosome, of rudimental testis and the secretion at puberty of testosterone, her body was unable to 
detect it because of a receptor dysfunction due to a mutation of a gene on the Y chromosome. Without the 
stimulation provided by the masculine hormone, her body developed a female phenotype but did not have 
any competitive advantage (Blackless et al., 2000; Fausto-Sterling, 2000; Dickinson et al., 2002; Peel, 
1994; Martínez-Patiño, 2005). The restatement of Maria Patiño as a woman for sport was an important step 
in the consideration of sex not as a well defined status but as a continuum from two extremes, the male and 
female sexes, with a wide variety in the middle (Fausto-Sterling, 2000). 
 
GENDER VERIFICATION TESTING IN HIGH LEVEL SPORTS 
 
Gender verification was introduced by the IOC to avoid the fraudulent participation of men in female only 
competitions, but it caused the exclusion from competitions of athletes with genetic disorders that did not 
have any advantage over female athletes. The gender verification in sport had origin in 1948 when the 
British Women’s Amateur Athletic Association required a doctor’s letter certifying the sex of women 
competitors. Soon in 1966, considering that this method was poorly effective an inspection in front of a 
panel of three women doctors was required at the Budapest European Track and Field Championship. At 
the 1966 Commonwealth Games in Kingston, a manual examination of the external genitalia was carried 
out by a gynaecologist on all female athletes, and in 1967, at the European Cup final in Kiev, close-up 
visual inspection of genitalia was used to establish eligibility (Facius, 2004). Afterwards, in the 
Commonwealth Games in Jamaica a manual examination of the external genitalia was performed by a 
gynecologist (Ferris, 1992; Ferguson-Smith, 1998). Also, in Canada at the Pan American Games a visual 
inspection was carried out (Elsas et al., 2000).  
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After the questioning of the true sex of some women athletes at the European Track and Field 
Championship held in Budapest, the gender verification test included a method consisting of buccal smear 
and x-chromatin analysis to rapidly determining the sex of participants (Hay, 1972). This method rapidly 
extended to other international events (Hay, 1972). Examination of cells from the buccal mucosa shows a 
chromatin mass, the Barr bodies, which probably represent an inactive X chromosome attached to the 
nuclear membrane in most female cells (Barr, 1972). The number of the Barr bodies is one less than the 
number of chromosome and they are absent in male. This method was applied due to its rapid realization 
which gave the possibility to check the gender of a large number of athletes in a relatively short time and 
because it was inexpensive. The purpose of the buccal smear was to avoid the shame of athletes to 
undress and the degrading inspection in front of a panel of gynaecologists (Anonymous, 1967; Genel, 
2002).  
 
While chromosomal analysis may take several days to obtain results, chromatin stains can help to 
determine the presence or absence of a second X chromosome and fluorescent Y stains can help identify 
the Y chromosome (Moore, 1966). Some patients may exhibit asymmetrical staining suggesting genetic 
mosaicism (Ogilvy-Stuart & Brain, 2004). Nevertheless, the buccal smear method is not accurate in 
determining the chromosomal pattern, since the absence of Barr bodies could be due not only to 46/XY 
normal males, but also to 45/XO (Turner's syndrome), or mosaics in which different body tissues have a 
different chromosomal make-up. Also, chromatin-positive persons may be 46/XX (normal female), 47/XXX 
(triple-X syndrome), 47/XXY (Klinefelter's syndrome), or mosaics (Anonymous, 1967; de la Chapelle, 1986; 
Daher et al., 1986). Since 1970s, this method has been discarded by several scientists as common 
diagnostic tool because technically unreliable (Simpson et al., 1993; Dickinson et al., 2002): women, who 
have genetic abnormalities that offer no conceivable strength advantage, are disqualified unfairly, while 
some men with genetic disorder would pass the sex chromatin test. A complete study of the kariotype is 
determined only in case of doubt because of its cost and of the prolonged time that it requires.  Although a 
number of scientists published objection in medical journals (de la Chapelle, 1986a, 1986b, 1987, 1988) 
and in 1988 a meeting was promoted by the genetist de la Chapelle, the IOC did not change its policy (de 
la Chapelle, 1988; Elsas et al., 2000). In the same year, Maria Patiño, after two years of fights and with the 
help of specialists in endocrinology and genetics, obtained the reinstatement as a woman for sport and the 
possibility to compete in women only competitions. 
 
The IAAF promoted symposia and work groups of scientific experts in Monte Carlo in 1990 and in London 
in 1992, accepting the results pointed out, so that individuals with genetic abnormalities raised as females 
and with no unfair physical advantages (including those with 21-steroid-hydroxylase and 5-α-steroid-
reductase deficiency, incomplete androgen insensitivity and chromosomal mosaicism) should be admitted 
to compete, as the individuals that underwent sex rearrangement surgery in prepubertal age, while post-
pubertal transsexual cases should be considered case by case; also they advised about the need to 
abandon screening of athletes through genetic testing of Y chromosome (Hipkin, 1991; Simpson et al., 
1993; Elsas et al., 2000). 
 
The International Olympic Committee (IOC) did not follow the same path and decided to introduce since 
1992 in Albertville a more modern scientific technique, the Polymerase Chain Reaction (PCR) analysis of 
the Sry gene. However, this method is able to provide information of the presence of Y chromosome also in 
female pseudohemaphroditism so that its use seems to be limited (Fausto-Sterling, 2000; Sultan et al., 
2002). Considering the protocol used at the Barcelona Olympic Games of 1992 (Serrat & García de 
Herreros, 1996) and the results showing incongruity between expression of SRY and DYZ1 sequences on 
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the Y chromosome and the higher likelihood of finding DYZI sequences in female athletes as opposed to 
unselected female controls further our understanding of the technical limitations of this test (Puffer, 1996). 
 
At the 12th Asian Games in Hiroshima in 1994 a study (Yamaoka & Kanbe, 1995) on the human genomic 
DNA extracted from the hair root of female competitors was used to validate the method of the Polymerase 
Chain Reaction (PCR) in order to prove the absence of the sex determining region of Y-chromosome (SRY) 
and confirm the femininity, and detection of pseudo autosomal boundary region of Y-chromosome (PABY).  
 
In 1994 the Norway government denied the IOC gender verification tests during the Lillehammer Olympic 
Games declaring the tests illegal and unethical (Elsas et al., 2000; Ljungqvist et al., 2006). Advised of the 
ethical and technical inappropriateness of the techniques used so far, the IOC decided in 1999 to suspend 
the gender verification in all sports events which sponsored, maintaining a conditional basis for later review.  
The International Volleyball Federation was the last institution to leave the gender verification testing in 
2004 (Genel & Ljungqvist, 2005). 
 
Athletes with some DSD have either avoided the gender verification for the fear to view their condition 
publicly divulgated on the mass media or were excluded from competitions though they did not suspect 
irregularities in their chromosomal arrangement, as the cases of the sprinter Ewa Klobukowska and the 
hurdler Maria Patiño. After a hard fight with the help of scientists and experts, Maria Patiño obtained her 
reinstatement as woman for sport and was allowed to compete (Carlson, 2005; Martínez-Patiño, 2005). Her 
efforts served as first action towards the abolition of the gender verification in international competitions, but 
the repercussion on her personal life was devastating (Peel, 1994). 
 
Under external pressure, the IOC adopted a policy enabling transsexual athletes to compete in the 2004 
Olympic Games held in Athens (Gooren & Bunck, 2004; Cavanagh & Sykes, 2006) with the condition that 
they should have two years post surgery and continued hormone therapy (Carlson, 2005).  In this sense, 
the policy recommended by the IOC might suggest that thought that this finally closed a difficult chapter in 
the path towards full integration of women in sport (Elsas et al., 2000; Simpson et al., 2000; Dickinson et 
al., 2002; Ljungqvist et al., 2006). Nothing is farther from the reality because the transgender policy is 
strictly limited to athletes who have undergone sex reassignment (it has nothing to do with DSD athletes) 
and the fact the womanhood of a South African athlete, Caster Semeya, winner in the 800 meter athletic 
specialty in the 2009 Summer World Championships held in Berlin, was questioned, when medical aspects 
that should have treated with totally and absolutely confidentiality about this case according to the rigor of 
strict medical ethics were leaked to the press. One may well ask how this conduct represents a deviation 
from the previous practices and if a real change has been done in the IOC policy. In fact the IOC 
conditioned the suspension of the sex test and gender verification to the right to inspect those female 
athletes suspected of gender ambiguity (Cole, 2000).  
 
After the Caster Semenya case, the IOC organized a meeting in January 2010 in Miami where the most 
eminent scientists in the field were invited to address the specific problems of assigning sexual 
identification and propose new methods based on modern techniques. The Committee is now considering 
the possibility to give the responsibility of gender verification tests to specialized centers disseminated all 
over the world, conscious that not all countries have the same level of technology.  
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DISCUSSION 
 
The IOC policy simply says that the medical authority at a competition should have the right to conduct an 
investigation into an athlete’s sex, if that is deemed wishful to identify the sex ambiguities of the athletes 
based on the assumption of a clear and absolute dimorphism in humans, so that only two sex classes are 
considered (male and female). As observed by Conte and Grumbach (1989) and by Blackless et al. (2000) 
this absolute separation does not exist. IOC often confuses sex with gender, when they are completely 
separate concepts: scientists define sex according to physical characteristics, while gender is a social 
concept and coincide with the psychological conviction that one is male or female, the so called gender 
identity (Fausto-Sterling, 2000; Wilson, 2000). The practice of sex testing actually makes visible both the 
construction of sex categories and the oppressiveness of their application by sport institutions (Wackwitz, 
2003).  
 
The life and the career of Caster Semenya, as occurred to others in her situation in the past, have been 
irremediably changed and nothing would be as before of the gender verification test.  IOC and IAAF tried to 
use science to decide if some males have perpetrated a fraud to get into women's competition and if a 
deliberate fraud has been committed. Along the years they innovated the methods but not the aim, trying to 
fit different individuals into two categories when scientists and experts warned about the impossibility and 
the lack of ethics of their attitude. 
 
At the beginning of the twenty-first century, with the support of ongoing medical research in the fields of 
diagnosis and treatment of complex sex determination in humans, it is necessary to establish parameters to 
determine with scientific rigor genetic issues. Hormonal, biological and psychological factors must be taken 
into account where uncertain or ambiguous cases in female athletes occur and must be considered eligible 
to participate in sporting events. These disorders of sexual differentiation in sports have existed, exist and 
will always exist, and it is high time to determine with medical facts what to do in these situations.  
 
Psychological and social repercussions of gender verification 
 
Many factors are involved in sexual identity beyond chromosomal makeup such as an early imprinting of 
the brain based on hormonal exposure (Diamond, 2002), a complex interaction between prenatal and 
postnatal endocrine factors, genetic influences, and postnatal environmental and psychological 
experiences.  Science has revealed many of the genetic and hormonal pathways responsible for inter-sex 
disorders (Forest, 2001), but the psychological aspects of the physical statement of gender assignment 
could perhaps be even more critical in the final picture of social adjustment, and are still poorly understood 
(Bomalaski, 2005).  
 
Gender verification testing of women in international competitions could be considered as an abusive, 
unethical and discriminative practice which was carried out by high level sports institutions for decades. 
The need to apply a gender verification test was considered in response to the masculine aspect of some 
Soviet champions during the Cold War. The nationalism feelings of Americans could not afford the 
hegemony of athletes from Soviet Union in many sports, so that they hypothesized the unfair participation 
of men in women only competitions or the belief that hormone therapy was applied by Soviet trainers to 
change boys in girls or virilizing female athletes (Wiederkehr, 2009). The gender verification seemed the 
best solution to avoid dishonest participations in female only competitions. Only two men have been 
confirmed to have competed in female events pretending to be women in the 1940s and 1960s. 
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When they have to submit to routine gynecological examination, most women suffer episodes of shame 
and decency due to the uncomfortable feelings of being observed by a stranger.  If we also consider that in 
the past, and still today in less developed countries, women did not undergo to gynecological examinations 
unless they did not have a serious problem, we could imagine the feelings of thousands of women that 
passed through the genital examination of the gender verification process until 1967. It is not surprising that 
some women refused to subjugate to these unpleasant practices, as occurred when this system was 
applied for the first time. Six women did not present to the gender verification in that occasion, including 
Tamara and Irina Press, the two Soviet sisters who were the greatest athletes of that époque (Carlson, 
2005). Although supposing that the absence of these athletes at the gender verification was due only on 
the basis of emotional causes or an injury could appear too simple and ingenuous, no real proof of 
irregularities in their genitals or chromosome arrangement has been provided. We can only hypothesize 
that they probably were affected by some kind of disorder of sex development, showing some abnormalities 
in their external genitalia. In front of the possibility of being object of examination, of discrimination and 
viewing publicly divulgated their condition, these and other women preferred to withdraw before to submit to 
gender verification tests (Elsas et al., 2000). On the other hand the two champions declared that their 
absence from competitions was not due to the examination of the gender verification itself (Wiederkehr, 
2009), although their absence enhanced the gossip that they would probably fail the test. Also at that time 
there was a great confusion on what was the range of the gender verification, which in many cases was 
confused and correlated with the drug testing (also introduced in 1967). The use of anabolic steroids to 
enhance muscular development and strength caused alteration of the female phenotype, such as 
deepening voice and facial hair growth, so that the masculine aspect of the athletes was considered 
checkable with a gender test.   
 
The introduction of the chromatin test, which many problems of shame and protests should solve, was the 
cause of injustice and discrimination along the woman history of sport. The knowledge about people with 
disorders of sex development was limited and not available to everyone, and less to people who were 
unaware or unable to understand genetic issues. Many women were asked to graciously withdraw from 
sport life or to pretend a serious injury when obtaining a positive result from the gender verification test by 
buccal smear, probably a number much higher than we suspect (Elsas et al., 2000; Martínez-Patiño, 2005; 
Fox, 1993; Genel, 2002). Without any doubt the gender verification system ended with their sports careers, 
but the devastating repercussion on the personal and social lives of those individuals whose stories were 
leaked to the mass media (Wiederkehr, 2009) is another matter: suddenly they were not women any more, 
nor they were considered men. The social rejection and the affliction in most cases affected also the family 
and friends of subjects with DSD, and unfair attitude remains after the death of the interested person, as 
was for the athlete Stella Walsh. She was reared as girl at birth, was raised as female, got married, and 
competed at high level, but after her death and the public divulgation of her mosaic chromosomal pattern 
and abnormality of genitals she is still referred as “he/she” in many records books (Carlson, 2005).    
 
The same psychological problems experimented in sport by individuals with clear genital abnormalities 
were even harder to board when the abnormalities were unsuspected. Most of male pseudohermaphrodites 
are reared as female at birth, raised as female and in many cases unaware of their different condition. Ewa 
Klobukowska and Maria Patiño, for example, knew their disorder of sex development by the gender 
verification test and never before they have considered themselves something different than normal 
women. After her obligated retirement from competitions and the retirement of all her medals and records, 
Ewe Klobukowska felt a deep depression and decided to undergo surgery and to follow a hormone therapy 
to reassess her sex as woman. She broke off all the contacts with the sports world (Langlais, 1988; Facius, 
2010; Carlson, 2005). Maria Patiño was advised to pretend an injury and quietly withdraw, when her gender 
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test gave positive. She considered herself nothing different of a female so refused to leave competition and 
was disqualified in 1985. Her willpower allowed her not to give up with sport, to investigate the cause of her 
difference and to look for help in experts of both medical and sport fields to be restated as woman for sport. 
During her hard struggle she had suffered the mock of people who called her witch, the continuous 
rumours, the impotence to see her parents and family suffering for the situation, the lose of the closest 
people such as her boyfriend and her friends. She had to submit to public shame and to internal 
questioning about herself, convinced in all moment of her honesty and her womanhood (Peel, 1994; 
Carlson, 2005; Cavanagh & Sykes, 2006; Martínez-Patiño, 2005). Only 50% of undervirilized 46,XY 
subjects obtain a definitive diagnosis (Houk et al., 2006) and she probably would never be aware of the 
atypical chromosome pattern if she did not practice high level sport. Caster Semenya declared her 
womanhood in front of sport institutions and after the failure of the gender test she affirmed to be a female 
as she was always reared. When her condition was divulgated to the press and other media, a part to have 
to deal with an internal conflict and challenge, she experimented the beginning of a discriminatory attitude 
from the society and the insistent interest of people to all what concerns her condition.  
 
Sexual boundaries are not so defined and separated in two classes (male and female) as the society and 
sports institutions generally intend, being present a wide range of intermediate sexual conditions which 
have to be taken into account. The IOC decision at the Miami meeting to create centers where the athletes 
with ambiguous genitalia or atypical chromosome arrangement will be treated with the privacy that the 
instance deserves is a step towards the reach of good practices in gender verification. The multidisciplinary 
approach of these centers should include a protocol sufficiently flexible and diversified to consider the 
different facets of such kind of situations including a psychological support for the athletes and if opportune 
for the family. To minimize the psychological distress, the subject/family should be informed exactly and 
clearly about the kind of assays and the consequences of the possible results.  
 
We agree that a control on the medical conditions should be conducted for the health of the athletes, 
indistinctly for men and women, and we pretend that the gender verification change its discriminative 
perspective against DSD athletes at the same time that a more ethical and sensitive attitude is adopted by 
sports institution in considering each situation. People reared as female at birth and grown up as female, 
should not be consider differently by sports institutions though their chromosomal arrangement is different 
from the expected. An endogenous advantage given to the athletes by their DSD condition over 
competitors is not easily quantifiable and should not be quantified as should not in other kinds of genetic 
mutations that do not affect sex and gender assignment but that give a phenotype that favors the 
excellence in a particular sport activity. On the other hand, sportsmen and sportswomen should be 
informed on their health problems with the assistance of psychologists and well trained physicians.  
 
The time of fraudulent intents of some men to participate in women competitions is very far (only one men 
was confirmed to participate in women competitions and did not have any advantage over other 
participants since he classified fourth), and nowadays gender verification is out of meaning. It is important 
that the sports institution respect the psychosexual development of DSD athletes, giving them the 
opportunity to compete as men or women according to their gender assignment. 
 
Above all, the medical decision should be the unquestionable parameter for determining gender sports 
eligibility. These cases are no longer an issue to be analyzed from the sports point of view, but from a 
medical one and should under no circumstances be exposed publicly as happened to Caster Semeya, 
where there was no discretion or consideration to protect the athlete from the difficult and tense situation 
that ensued.  
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Under the Medical Commission of International Olympic Committee and with the experience of many cases 
throughout decades of women participating in the Olympics, the controversy should end, based on taking 
the recommendations and advice of scientists in all medical fields of study, providing sports organizations 
and their leaders something they hope to achieve as well, the eradication of such unfortunate situations. 
These recommendations supported by the research of medical, ethical and sports experts will determine a 
substantial and specific way what can be done in such cases in the future.  
 
And above all, these decisions cannot be questioned by external and inexperienced individuals who only 
induce human trauma of great pain and frustration to the helplessness athletes and their families. Their 
whole future as human beings is full of doubt just for having chosen to do high-level sport, never having the 
intention to deceive anyone. Nobody can compare these present day situations to those fraudulent 
attempts in the decades of the 40s, 50s and 60s when some men intended to compete as women, 
specifically in the 1972 Munich Olympics it was alleged that one of the Asian women’s volleyball teams 
included a man. These circumstances are medically and psychologically different and in the 21st century 
are unthinkable. 
 
The imperfections of genetic testing which draw erroneous conclusions of their condition must not be used 
against women athletes nor allowed to be known by sports organizations in the media that slander the 
athlete. If this situation is not clarified and the recommendations of the experts are not taken into account, 
in the future women with an ambiguous condition will always be questioned, and they will feel helpless 
lacking the solid arguments needed to fight this discriminative attitude. Most importantly, at all times they 
must have the scientific, medical and human support to overcome the new reality they are facing. It is 
essential that experts take into account the need to include psychological support to affected women in 
order to help them to reintegrate into society accepting their particular condition. 
 
CONCLUSIONS 
 
For decades, women who belonged to a selective group of high level competition sports have undergone 
tests to ascertain whether they could be considered as “women” in order to participate in their respective 
sport categories. 
 
We have gone from the humiliating visual checks that were established in the beginning of times to later 
medical controls that reinstated this humiliation on the basis of science lacking a thorough basis in order to 
decide whether they should participate in sports or not, considering them genetically faulty side by side with 
others that were denominated “genetically correct,” according to the existing regulation. 
 
It was Prof. de la Chapelle, a specialist in genetics, who established a turning point and who showed the 
ruling committees of sports the mistakes and injustice that they were falling into by limiting the definition of 
gender in sports to a simple genetic control.  Much thought, controversy and struggle have been devoted to 
suppress the systematic controls that questioned many women who found in sports a way to project their 
talent and their abilities. 
 
These women, unfairly treated and hardly supported by the institutions that were supposed to defend them 
in sports, found in one of the leaders of the sports world, Prof. Arné Ljungqvist, a broader vision in order to 
elicit a solution and an adequate management of their situation. This way, their particular cases could be 
treated and analyzed individually by experts, out of the scope of the media, and within specialized centres 
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with the adequate advances of medicine in the field of sports. This “new age” in which a more humane, fair 
and confidential treatment is guaranteed would be the best way out to banish those humiliating situations of 
the past and recent past which made sport women and their families dramatically drag their personal 
histories as a heavy burden for the rest of their lives. 
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